In the current study, the relationship between FGF23 and cardiac hypertrophy differed according to CKD stage; therefore, whether or not differences between the various CKD stages might be explained by variations in the cardiac expression of FGFR4 awaits further investigation [7,8]. This evidence concerns the gene FGF23 and chronic kidney disease.